UM-HACC-2A: MYB-NFIB fusion-positive human adenoid cystic carcinoma cell line-Reference-Cited by-同舟云学术

UM-HACC-2A: MYB-NFIB fusion-positive human adenoid cystic carcinoma cell line

Published:2018-12 Issue: Volume:87 Page:21-28
ISSN:1368-8375
Container-title:Oral Oncology
language:en
Short-container-title:Oral Oncology

Author:

Warner Kristy A.,Oklejas Alexandra E.,Pearson Alexander T.,Zhang Zhaocheng,Wu Weishing,Divi Vasu,Rodriguez-Ramirez Christie^ORCID,Castilho Rogerio M.,Polverini Peter J.,Nör Jacques E.

Funder

NIH/NIDCR

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Oral Surgery

Reference48 articles.

1. An update on grading of salivary gland carcinomas;Seethala;Head Neck Pathol,2009

2. Recent advances in the diagnostic pathology of salivary carcinomas;Simpson;Virchows Arch,2014

3. Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies;Dodd;Oral Oncol,2006

4. Salivary gland cancers: current treatments, molecular characteristics and new therapies;Chandana;Exp Rev Anticancer Ther,2008

5. Adenoid cystic carcinoma: current therapy and potential therapeutic advances based on genomic profiling;Chae;Oncotarget,2015

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Establishment and characterization of cMYB-expressing human salivary adenoid cystic carcinoma cell lines (UM-HACC-14, UM-HACC-6) and matching patient-derived xenograft model (UM-PDX-HACC-14);Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology;2024-10

2. Reversible Downregulation of HLA Class I in Adenoid Cystic Carcinoma;2024-09-07

3. How predominant cell and stroma types harmonize to predict head and neck adenoid cystic carcinoma outcomes?;Medical Journal Armed Forces India;2024-07

4. Emerging role of MYB transcription factors in cancer drug resistance;Cancer Drug Resistance;2024-04-30

5. Drug Screening and Contrasting Sensitivities: Adenoid Cystic Carcinoma Cancer Stem Cells and Tumor Cells Differentially React to Histone Modifier Drugs;2024-03-07